Biol Reprod Keystone Symposia Conference on Frontiers in Reproductive Biology & Regulation of Fertility.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SHILLE, V. M.
Right arrow Articles by STABENFELDT, G. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SHILLE, V. M.
Right arrow Articles by STABENFELDT, G. H.
Agricola
Right arrow Articles by SHILLE, V. M.
Right arrow Articles by STABENFELDT, G. H.

Biology of Reproduction, Vol 21, 1217-1223, Copyright © 1979 by Society for the Study of Reproduction

Luteal Function in the Domestic Cat during Pseudopregnancy and after Treatment with Prostaglandin F2agr

V. M. SHILLE 1, and G. H. STABENFELDT 1

1 Department of Reproduction, School of Veterinary Medicine, University of California, Davis, California 95616


The effect of PGF2agr treatment on luteal function was studied in cats made pseudopregnant by coitus with vasectomized males. Luteal function was determined by the measurement of plasma progesterone. In 7 cats (12 cycles), prostaglandin F2agr-tromethamine (PGF2agr) was administered s.c. every 12 h on Days 11-15 or 21-25 postcoitum using doses of 220 or 440µg/kg (3 cycles/treatment). In untreated cats the mean interval from coitus to the start of the subsequent estrus was 45.4 days (SD = 8.0, n = 37) and the average period when mean plasma progesterone levels remained above 1 ng/ml was 37.4 days (SD = 5.1, n = 16). The responses to the 2 dose levels were not different and the data were pooled for this factor. The interval from coitus to subsequent estrus and the duration of the luteal phase were not significantly (P>0.1) affected by PGF2agr treatment. Progesterone concentrations, while not significantly (P>0.1) depressed during the Day 11-15 treatment period, rose subsequently to significantly (P<0.05) higher concentrations when compared with controls on Days 33 and 36 postcoitum. A significant (P<0.05) depression of progesterone content in plasma occurred during the treatment on Days 21-25. Follicle growth patterns, as indicated by plasma estradiol-17beta levels, were not affected by treatment with PGF2agr.

Note:
ACKNOWLEDGMENTS This work was supported in part by the Animal Protection Institute of America, Sacramento, CA and Companion Animal Laboratory Research Program, School of Veterinary Medicine, University of California, Davis.

Submitted on November 29, 1978
Accepted on September 7, 1979







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1979 by the Society for the Study of Reproduction.